(Q37970017)

26 August 2017

title

Advanced prostate cancer: reinforcing the strings between inflammation and the metastatic behavior (English)

1 reference

26 August 2017

0 references

1 reference

G Gueron

1

1 reference

26 August 2017

A De Siervi

series ordinal

2

1 reference

26 August 2017

E Vazquez

series ordinal

3

1 reference

26 August 2017

publication date

20 December 2011

1 reference

Prostate Cancer and Prostatic Diseases

26 August 2017

published in

1 reference

26 August 2017

volume

15

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

213-221

1 reference

26 August 2017

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Nuclear factor-kappaB in cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

B-cell-derived lymphotoxin promotes castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

The roles of prostanoids in infection and sickness behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

A ride on the ferrous wheel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Antitumor activity with CYP17 blockade indicates that castration-resistant prostate cancer frequently remains hormone driven.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

From pathogenesis to prevention of castration resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

The evolving role of oestrogens and their receptors in the development and progression of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Molecular mechanisms of castration-resistant prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Oxidative stress in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

The role of CXC chemokines and their receptors in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

From prostate to bone: key players in prostate cancer bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Expression and activation of alpha v beta 3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Tumor cell-specific blockade of CXCR4/SDF-1 interactions in prostate cancer cells by hTERT promoter induced CXCR4 knockdown: A possible metastasis preventing and minimizing approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Androgens Induce Functional CXCR4 through ERG Factor Expression in TMPRSS2-ERG Fusion-Positive Prostate Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

CXCL12 activates a robust transcriptional response in human prostate epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

The IL-8-regulated chemokine receptor CXCR7 stimulates EGFR signaling to promote prostate cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Minireview: Alternative activation pathways for the androgen receptor in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

The interleukin-8 pathway in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor-kappaB transcription and evasion of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Role of the protein tyrosine phosphatase SHP‐1 in Interleukin‐6 regulation of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Osteoblast-derived factors induce androgen-independent proliferation and expression of prostate-specific antigen in human prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Interleukin-6 regulation of prostate cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

aPKClambda/iota promotes growth of prostate cancer cells in an autocrine manner through transcriptional activation of interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Interleukin-6 regulates androgen synthesis in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

TNF is necessary for castration-induced prostate regression, whereas TRAIL and FasL are dispensable

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Castration resistance of prostate cancer cells caused by castration-induced oxidative stress through Twist1 and androgen receptor overexpression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Base excision repair of oxidative DNA damage and association with cancer and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Stress signaling in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Molecular alterations in primary prostate cancer after androgen ablation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Effects of manganese superoxide dismutase silencing on androgen receptor function and gene regulation: implications for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Androgenic regulation of oxidative stress in the rat prostate: involvement of NAD(P)H oxidases and antioxidant defense machinery during prostatic involution and regrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Gene expression profiling of androgen deficiency predicts a pathway of prostate apoptosis that involves genes related to oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Integrin and growth factor receptor crosstalk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

NF-kappaB in cancer: from innocent bystander to major culprit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Heme oxygenase-1: molecular mechanisms of gene expression in oxygen-related stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Catalytic inactive heme oxygenase-1 protein regulates its own expression in oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

PTEN deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Basic mechanisms responsible for osteolytic and osteoblastic bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Role of Wnts in prostate cancer bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Molecular biology of bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Matrix metalloproteinases and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Overexpression of Runx2 directed by the matrix metalloproteinase-13 promoter containing the AP-1 and Runx/RD/Cbfa sites alters bone remodeling in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Cancer to bone: a fatal attraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Bone-specific growth inhibition of prostate cancer metastasis by atrasentan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Clinical and pharmacodynamic evaluation of metronomic cyclophosphamide, celecoxib, and dexamethasone in advanced hormone-refractory prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Notch Signaling and ERK Activation Are Important for the Osteomimetic Properties of Prostate Cancer Bone Metastatic Cell Lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

JAGGED1 expression is associated with prostate cancer metastasis and recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Senescent stromal-derived osteopontin promotes preneoplastic cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Systemic endocrine instigation of indolent tumor growth requires osteopontin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Role of the metastasis-promoting protein osteopontin in the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Serum interleukin-8 is elevated in men with prostate cancer and bone metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2α

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

An IκBα phosphorylation inhibitor induces heme oxygenase-1(HO-1) expression through the activation of reactive oxygen species (ROS)-Nrf2-ARE signaling and ROS-PI3K/Akt signaling in an NF-κB-independent mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta3-integrin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.64

Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways

31 March 2020

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1002/JCB.22451

Identifiers

DOI

10.1038/PCAN.2011.64

1 reference

Dimensions Publication ID

26 August 2017

1049267395

0 references

1 reference